Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Cancer, Resected”

254 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 254 results

Not applicableStudy completedNCT02241187
What this trial is testing

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)UnknownNCT04617457
What this trial is testing

Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerMetastasisSurgery+1 more
University of Cologne 150
Not applicableNot Yet RecruitingNCT07621029
What this trial is testing

Venous Resection in Patients Undergoing Pancreatic Surgery

Who this might be right for
IPMN, PancreaticPancreatic Cancer, ResectedPancreatic Cancer Borderline+1 more
Sahlgrenska University Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT01964430
What this trial is testing

Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)

Who this might be right for
Pancreatic NeoplasmsDigestive System NeoplasmsNeoplasms by Site+7 more
Celgene 866
Not applicableLooking for participantsNCT05752812
What this trial is testing

The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Medical University of Vienna 1,500
Testing effectiveness (Phase 2)UnknownNCT00010062
What this trial is testing

Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Early research (Phase 1)Looking for participantsNCT06344156
What this trial is testing

Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdjuvant Therapy
Sichuan University 43
Large-scale testing (Phase 3)Ended earlyNCT00014651
What this trial is testing

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Who this might be right for
Pancreatic CancerPerioperative/Postoperative Complications
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00727441
What this trial is testing

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87
Not applicableUnknownNCT04136522
What this trial is testing

Usefulness of the Artery First Approach in Pancreatic Cancer Surgery

Who this might be right for
Pancreatic Cancer, AdultMargin, Tumor-FreeSurgery Site Fistula+1 more
Asan Medical Center 268
Not applicableLooking for participantsNCT04571294
What this trial is testing

Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy

Who this might be right for
Pancreas CancerPancreaticoduodenal LymphadenopathyPancreas Adenocarcinoma
Humanitas Hospital, Italy 180
Testing effectiveness (Phase 2)Study completedNCT01845805
What this trial is testing

Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 49
Not applicableStudy completedNCT00062166
What this trial is testing

Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau Disease
National Cancer Institute (NCI) 340
Large-scale testing (Phase 3)Not Yet RecruitingNCT07591493
What this trial is testing

Adjuvant Trial in Pancreatic Neuroendocrine Tumors

Who this might be right for
Pancreatic Neuroendocrine Tumors (pNET)Pancreatic Neuroendocrine Tumors
Gustave Roussy, Cancer Campus, Grand Paris 300
Testing effectiveness (Phase 2)Ended earlyNCT06069778
What this trial is testing

Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
BioNTech SE 1
Not applicableLooking for participantsNCT05524090
What this trial is testing

PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic AdenocarcinomaPancreatic Adenocarcinoma Non-resectable+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 223
Testing effectiveness (Phase 2)Active Not RecruitingNCT05968326
What this trial is testing

The Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

Who this might be right for
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc. 260
Early research (Phase 1)Active Not RecruitingNCT04117087
What this trial is testing

Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer

Who this might be right for
Colorectal CancerPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Not applicableStudy completedNCT07414004
What this trial is testing

Comparison of Prognosis Between Open Pancreatic Surgery With Vein Resection and Reconstruction Versus Minimally Invasive Pancreatic Surgery With Vein Resection and Reconstruction for Pancreatic Cancer

Who this might be right for
Pancreatic Tumor Patients Who Consecutively Underwent Minimally Invasive or Open Pancreatic Surgery With Venous Reconstruction
First Affiliated Hospital Xi'an Jiaotong University 2,451
Not applicableStudy completedNCT06461598
What this trial is testing

Signature for Precise Chemosensitivity Prediction in PDAC

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 365
Next Page